NTLA Intellia Therapeutics Inc

$NTLA Great close ! Within 6 months this company will have the first In Vivo Crisper therapeutic FDA approved !!!!!

$NTLA Intellia Therapeutics Announces Upcoming Lonvoguran Ziclumeran (Lonvo-z) Investor Event and Seven Presentations at ACAAI 2026

$NTLA and another 510 k for Caty 29 sept 205.192 30 sept 466.956 1 oct 410.911 2 oct. 511.697 Totals: 1.594.756 shares.

$NTLA So the same analyst that gave NTLA a $14 price target last year bear before BLA submission is now giving a target of 8. Barclays want in, but they want in at a cheap price. I hope it backfires

$NTLA sooo, Intellia friends, the game is on. According to the pressrelease , i am pretty sure that q3 presentation wil be given after ACAAI. Which creates another momentum . Also interviews will be given. This is a well Orchestrated PR action. As expected btw. Well done Intellia.

$NTLA The risks here are 110% priced in. The upside is about 10% priced in. So owning NTLA is both scary and exciting.

$NTLA Shorts are running out of time. How long they will be able to manipulate? Approval is almost certain and probably in Feb of next year

$NTLA NTLA: The Gene-Editing Revolution Is Becoming Reality! 🚀🧬 Intellia Therapeutics is pioneering a future where genetic diseases could be treated with a single intervention. Its groundbreaking CRISPR therapy, lonvo-z, demonstrated an extraordinary 87% reduction in hereditary angioedema attacks during Phase 3 trials. With FDA Priority Review, a March 2027 decision approaching, and potential commercialization ahead, Intellia stands at a historic turning point. Strong clinical results and advancing gene-editing technology create tremendous opportunities. Despite regulatory and commercial risks, NTLA could help redefine modern medicine, transforming scientific breakthroughs into life-changing treatments for millions worldwide.

$NTLA CW is gonna blow up the shorts that's for sure... She's done it with $TSLA ... See it happening here again... 🤔🤔🤔

$NTLA like I said let it ride 10-12 percent short it 8 percent repeat until bankruptcy it’s been doing this for 3 years and bulls wonder why the short interest is 35% your precious Intellia is a losing bet all up will be followed by a equal if not more substantial drop this is going nowhere

$NTLA Shorts continue to be relentless. Such a sad irony that a promising company that is working to improve life for humanity Is the target of such unending short selling.

$NTLA Dr. Jing L. Marantz is a highly experienced biotechnology executive with more than 25 years in drug development, particularly rare diseases. Why her appointment matters for NTLA I consider this a positive strategic appointment for three reasons. Regulatory experience: She has helped companies navigate FDA and international regulatory processes, which is particularly valuable as Intellia advances toward potential product approvals. Rare-disease commercialization: She has experience taking therapies beyond clinical trials into commercial use. Relevant technology experience: Her background at Alnylam and Krystal Biotech gives her exposure to RNA therapeutics and gene therapy, although that does not automatically establish direct CRISPR gene-editing expertise. Intellia says she will oversee clinical development, regulatory affairs, translational medicine and medical affairs.

$NTLA Every time I hear about Cathie Woods hoovering up more NTLA shares, I ask myself a question: Is there any argument against buying ntla that she has not heard, researched thoroughly, considered, and dually dispensed with before counting to make her aggressive purchases? Once I've answered that question with a no, and I see that she is still aggressive in her buying, I feel more confident in my own purchases. And that is despite what some of her detractors say about her being a reverse indicator regarding her investment choices.

$NTLA the daily pill Oraldeyo for HAE retails at $1700 per pill! Cheaper wholesale, but insurance companies are still looking at 500K per year! Lonovo-z is onetime, but with 4 to 6 times that cost - so thats recoverable in 4-6 years. Intellia is apparently working on payment agreements, especially for situations where insurance companies change - it’s likely they will figure something out. From the patient perspective - what would you prefer if the insurance is going to pay for the pill or the one time treatment? Given the steep cost of the pill why would I want to take on the uncertainty of high insurance payments every year through the rest of my life? I would likely opt for the one time cure - and the strong interest in signing up for Clinical Trials is a very positive sign. Then there’s nex-z! Thats much larger, even if the issues are very similar. I think Gena Wang got this one wrong.

$NTLA Hahaha, Barclay James Harvest, those greedy little bastards are your original market manipulators of the worst and most obvious kind. Great for anybody who thinks about opening a position in NTLA. I actually think that this is a bullish sign mid-term. Will stack up once the smoke clears. Laugh at it and be a little patient, at least that’s my strategy.

$NTLA I think whats interesting about gene editing that is different is for markets like HAE, once NTLA starts in on it, the market shrinks which sounds bad but it also means nobody will want to try to enter it because its getting smaller. Leaving all the pie for NTLA, same for ATTR or any functional cures

$NTLA damn these bulls don’t learn all ya got to do is bate the hook and the shorts reel them in 😂

$NTLA Gena Wang had me scared there for a couple of seconds. But I think I overestimated her skill, insight, and experience. However, if she has any surplus shares for $8 or $9, I would be a buyer.

$NTLA 1/2 a position.. let’s go 🐻 🐻 bring it down so I can 🐂 rush more tranche.. one time treatment with gene 🧬 editing? First move advantage playing out Happy Taco Tuesday y’all

$NTLA CW is going for the kill... Don't miss the opportunity...Guaranteed approval no doubt about it.. Guaranteed adoption imo... First by early adopters and very soon after followed by the rest in a year or 2... 😎😎😎